UNSPSC 51283950: Sulfaproxyline

This classification denotes a sulfonamide anti-infective agent with the molecular formula C16H18N2O4S, a preparation that US FDA recognizes as an active ingredient or moiety under Unique Ingredient Identifier YR841R53VW, chemically known as benzamide, p-isopropoxy-n-sulfanilyl- (8ci) but more generally known as sulfaproxyline, which bears U.S. National Institutes of Health Compound Identifier 67002. The European Medicines Agency schedules Sulfaproxyline in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB10722MIG.

The term SULFAPROXYLINE is an International Non-Proprietary Name or INN (see World Health Organization INN reference publication, Volume 13, No. 12, 1959, List 3). SULFAPROXYLINE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. SMILES: S(=O)(=O)(NC(=O)C1CCC(OC(C)C)CC1)C1CCC(N)CC1.

UNSPSC 51283950 Sulfaproxyline is a Commodity code that in practice encompasses pharmaceutical products and related health-supply procurement by state and local health departments and county health authorities. Recent state and local opportunities tagged under this code show issuing bodies acquiring antibiotics, opioid-reversal agents, and drug deactivation systems through competitive bidding processes, typically structured as fixed-fee contracts with multi-year terms and renewal options. The work involves sourcing finished pharmaceutical products in unit quantities specified by health agencies, negotiating pricing on a per-unit or per-order basis, managing quarterly or as-needed delivery schedules to designated health facilities, and meeting standard contractor compliance requirements including drug-free workplace certification, E-Verify verification, and insurance coverage thresholds.

The Illinois Department of Public Health and Seminole County, Florida are the recent visible buyers under this code. Illinois awarded a $2,999,999.11 piggyback pharmaceutical warehouse contract through the MMCAP Infuse consortium to Chartwell Rx LLC in August 2026 for supply of Doxycycline Hyclate 100mg and Ciprofloxacin Hydrochloride 500mg tablets over a three-year term with 12-month initial and two renewal periods. Seminole County posted an IFB in June 2026 seeking 1,900 units of Naloxone and 800 Safe Drug Deactivation Systems annually with quarterly deliveries to its Community Health Building in Sanford, Florida, on a two-year contract with one-year renewal option; that solicitation carried a response deadline of July 26, 2023. Procurement activity under this code appears concentrated in health and emergency-response contexts within Florida and Illinois, though the limited recent-opportunity sample constrains geographic characterization.